Lisa R. King

5.0k total citations
59 papers, 3.1k citations indexed

About

Lisa R. King is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, Lisa R. King has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 28 papers in Epidemiology and 23 papers in Virology. Recurrent topics in Lisa R. King's work include Influenza Virus Research Studies (19 papers), Respiratory viral infections research (14 papers) and HIV Research and Treatment (13 papers). Lisa R. King is often cited by papers focused on Influenza Virus Research Studies (19 papers), Respiratory viral infections research (14 papers) and HIV Research and Treatment (13 papers). Lisa R. King collaborates with scholars based in United States, Canada and Thailand. Lisa R. King's co-authors include Hana Golding, Jody Manischewitz, Surender Khurana, Dorothy E. Scott, Marina Zaitseva, Philip R. Dormitzer, Thomas B. Kepler, M. Anthony Moody, Hua‐Xin Liao and Stephen C. Harrison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lisa R. King

57 papers receiving 3.0k citations

Peers

Countries citing papers authored by Lisa R. King

Since Specialization

Citations

This map shows the geographic impact of Lisa R. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa R. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa R. King more than expected).

Fields of papers citing papers by Lisa R. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa R. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa R. King. The network helps show where Lisa R. King may publish in the future.

Co-authorship network of co-authors of Lisa R. King

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa R. King. A scholar is included among the top collaborators of Lisa R. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa R. King. Lisa R. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus 2024 ·Nature Medicine ·Surender Khurana, Lisa R. King, Jody Manischewitz, (unknown), (unknown), Dongxiao Liu, John H. Beigel, Rino Rappuoli, John S. Tsang, Hana Golding	23
2	Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis 2023 ·BMC Infectious Diseases ·María Calderón, (unknown), (unknown), (unknown), Lisa R. King, Daniel Comandé, Ewan Hunter, Brendan Payne	23
3	Abstracts for the 43rd Human Genetics Society of Australasia Annual Scientific Meeting 2019 ·Twin Research and Human Genetics ·Lisa R. King	1
4	Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans 2019 ·Nature Communications ·Surender Khurana, Megan Hahn, Elizabeth M. Coyle, Lisa R. King, Tsai-Lien Lin, John J. Treanor, Andrea J. Sant, Hana Golding	65
5	AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization 2018 ·npj Vaccines ·Surender Khurana, Elizabeth M. Coyle, Jody Manischewitz, Lisa R. King, Jin Gao, Ronald N. Germain, Pamela L. Schwartzberg, John S. Tsang, Hana Golding, Angélique Biancotto, Julián Candia, Jinguo Chen, Foo Cheung, Howard B. Dickler, Yuri Kotliarov, Shira Perl, Rongye Shi, Katherine E. Stagliano, Neal S. Young, (unknown)	46
6	Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy 2017 ·Journal of Translational Medicine ·Meghali Goswami, Gabrielle T. Prince, Angélique Biancotto, Susan Moir, Lela Kardava, Brian H. Santich, Foo Cheung, Yuri Kotliarov, Jinguo Chen, Rongye Shi, Huizhi Zhou, Hana Golding, Jody Manischewitz, Lisa R. King, Lauren Kunz, Kimberly Noonan, Ivan Borrello, B. Douglas Smith, Christopher S. Hourigan	36
7	Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization 2015 ·PLoS ONE ·Surender Khurana, Elizabeth M. Coyle, Jody Manischewitz, Lisa R. King, Glenn Ishioka, Jeff Alexander, Jon Smith, Marc Gurwith, Hana Golding	17
8	Human T-Cell Lymphotropic Virus Type 1 Exposures Following Blood-borne Virus Incidents in Central Australia, 2002-2012 2014 ·Clinical Infectious Diseases ·Saliya Hewagama, Smita Krishnaswamy, Lisa R. King, Joshua S. Davis, Rob Baird	9
9	Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency 2014 ·Vaccine ·Surender Khurana, Lisa R. King, Jody Manischewitz, Elizabeth M. Coyle, Hana Golding	33
10	A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response 2014 ·The Journal of Infectious Diseases ·Kawsar R. Talaat, Catherine J. Luke, Surender Khurana, Jody Manischewitz, Lisa R. King, (unknown), Ruth A. Karron, Kristen Lewis, Jing Qin, Dean Follmann, Hana Golding, Kathleen M. Neuzil, Kanta Subbarao	76
11	DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults 2013 ·The Journal of Infectious Diseases ·Surender Khurana, Jian Wu, (unknown), Lisa R. King, Jody Manischewitz, Barney S. Graham, Julie E. Ledgerwood, Hana Golding	44
12	Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody 2012 ·Proceedings of the National Academy of Sciences ·Aaron G. Schmidt, Huafeng Xu, Amir R. Khan, Timothy J. O’Donnell, Surender Khurana, Lisa R. King, Jody Manischewitz, (unknown), Pirada Suphaphiphat, Andrea Carfı́, Ethan C. Settembre, Philip R. Dormitzer, Thomas B. Kepler, Ruijun Zhang, M. Anthony Moody, Barton F. Haynes, Hua‐Xin Liao, David E. Shaw, Stephen C. Harrison	196
13	A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells 2011 ·PLoS ONE ·Hanxin Lu, Surender Khurana, Nitin Verma, Jody Manischewitz, Lisa R. King, John H. Beigel, Hana Golding	17
14	Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets 2009 ·PLoS Medicine ·Surender Khurana, Amorsolo L. Suguitan, Yonaira M. Rivera, Cameron P. Simmons, Antonio Lanzavecchia, Federica Sallusto, Jody Manischewitz, Lisa R. King, Kanta Subbarao, Hana Golding	150
15	Clinical and Immunological Comparison of Smallpox Vaccine Administered to the Outer versus the Inner Upper Arms of Vaccinia-Naive Adults 2006 ·Clinical Infectious Diseases ·Kirk H. Waibel, Hana Golding, Jody Manischewitz, Lisa R. King, Margret Tuchscherer, Richard Topolski, Douglas S. Walsh	7
16	Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge 2005 ·The Journal of Infectious Diseases ·Yvette Edghill‐Smith, Mike Bray, Chris A. Whitehouse, David Miller, Eric M. Mucker, Jody Manischewitz, Lisa R. King, Marjorie Robert‐Guroff, Anna Hryniewicz, David Venzon, Clement A. Meseda, Jerry P. Weir, Ayşegül Nalça, (unknown), Jay Wells, Mark G. Lewis, John W. Huggins, (unknown), Hana Golding, Genoveffa Franchini	75
17	CCR5 N-terminal Region Plays a Critical Role in HIV-1 Inhibition by Toxoplasma gondii-derived Cyclophilin-18 2005 ·Journal of Biological Chemistry ·Hana Golding, Surender Khurana, Felix Yarovinsky, Lisa R. King, (unknown), Liselotte Antonsson, Christer Owman, Emily J. Platt, David Kabat, John F. Andersen, Alan Sher	10
18	Structural Determinants of the Anti-HIV Activity of a CCR5 Antagonist Derived from Toxoplasma gondii 2004 ·Journal of Biological Chemistry ·Felix Yarovinsky, John F. Andersen, Lisa R. King, Patricia Caspar, Júlio Aliberti, Hana Golding, Alan Sher	23
19	Development of a Novel Vaccinia‐Neutralization Assay Based on Reporter‐Gene Expression 2003 ·The Journal of Infectious Diseases ·Jody Manischewitz, Lisa R. King, (unknown), Joseph Shiloach, Rolf E. Taffs, Michael Merchlinsky, Nancy Eller, Malgorzata G. Mikolajczyk, David J. Clanton, Thomas P. Monath, Richard Weltzin, Dorothy E. Scott, Hana Golding	53
20	First episode schizophrenia and borna disease virus 1997 ·Schizophrenia Research ·Royce W. Waltrip, Jeffrey Lieberman, Delbert G. Robinson, Robert M. Bilder, José Alvir, Lisa R. King, Ann Summerfelt, Steven A. Rubin, Kathryn M. Carbone	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact